VENTURE CAPITAL FUNDING Solvay invests in DMC Biotechnologies to advance bio-based innovation

摘要

Solvay Ventures,the venture capital fund of Belgian chemicals major,Solvay,has invested in DMC Biotechnologies,a US-based biotechnology company.DMC,which stands for Dynamic Metabolic Control,delivers robust and predictably scalable biocatalysts through microbial fermentation.This results in cost-competitive bio-based chemicals produced for animal feed,human nutrition,sustainable cleaning and pharmaceutical applications.